Additive effects of atrial natriuretic polypeptide and of renal vasodilating agents in the anesthetized dog

Abstract

In order to examine the contribution of an increase in renal papillary plasma flow to the mechanism of natriuresis by atrial natriuretic polypeptide (ANP), we compared the natriuretic effects of ANP administered into the renal artery of the dog together with secretin or acetylcholine (ACh). At an equivalent renal vasodilating dose, ACh increased urinary excretion of sodium (U NaV) to 212 ± 36% of the control associated with a decrease in urine osmolality (62 ± 6%), whereas secretin did not change U NaV (113 ± 12%) or urine osmolality (101 ± 14%). This result was compatible with the view that ACh causes natriuresis mainly by increasing papillary plasma flow. Combined administration of ANP with secretin caused a marked increase in U NaV to 407 ± 55%, in association with a decrease in urine osmolality to 55 ± 9%, suggesting that ANP may cause natriuresis by a mechanism similar to that of ACh. Combined administration of ANP with ACh further increased U NaV to 323 ± 67% and decreased urine osmolality to 50 ± 6%. These observations suggest that ANP and ACh share common but not identical mechanisms of natriuretic action since ANP caused additional natriuresis during ACh infusion. These findings, however, do not necessarily exclude the possibility that ANP also inhibits renal sodium reabsorption by a direct action.